annual interest expense:
$1.68B+$93.00M(+5.85%)Summary
- As of today (May 29, 2025), AZN annual interest expense is $1.68 billion, with the most recent change of +$93.00 million (+5.85%) on December 31, 2024.
- During the last 3 years, AZN annual interest expense has risen by +$406.00 million (+31.82%).
- AZN annual interest expense is now at all-time high.
Performance
AZN Interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly interest expense:
$349.00M-$80.00M(-18.65%)Summary
- As of today (May 29, 2025), AZN quarterly interest expense is $349.00 million, with the most recent change of -$80.00 million (-18.65%) on March 31, 2025.
- Over the past year, AZN quarterly interest expense has dropped by -$64.00 million (-15.50%).
- AZN quarterly interest expense is now -23.63% below its all-time high of $457.00 million, reached on September 30, 2024.
Performance
AZN quarterly interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM interest expense:
$1.68B-$64.00M(-3.67%)Summary
- As of today (May 29, 2025), AZN TTM interest expense is $1.68 billion, with the most recent change of -$64.00 million (-3.67%) on March 31, 2025.
- Over the past year, AZN TTM interest expense has dropped by -$3.00 million (-0.18%).
- AZN TTM interest expense is now -4.55% below its all-time high of $1.76 billion, reached on September 30, 2024.
Performance
AZN TTM interest expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Interest expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
AZN Interest expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.8% | -15.5% | -0.2% |
| 3 y3 years | +31.8% | +3.9% | +28.2% |
| 5 y5 years | +20.0% | +5.1% | +22.8% |
AZN Interest expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.8% | -23.6% | +12.2% | -4.5% | +29.7% |
| 5 y | 5-year | at high | +32.2% | -23.6% | +21.6% | -4.5% | +35.3% |
| alltime | all time | at high | +1655.7% | -23.6% | +288.6% | -4.5% | >+9999.0% |
AZN Interest expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $349.00M(-18.6%) | $1.68B(-3.7%) |
| Dec 2024 | $1.68B(+5.9%) | $429.00M(-6.1%) | $1.74B(-0.9%) |
| Sep 2024 | - | $457.00M(+3.2%) | $1.76B(+3.8%) |
| Jun 2024 | - | $443.00M(+7.3%) | $1.69B(+0.7%) |
| Mar 2024 | - | $413.00M(-7.2%) | $1.68B(+2.9%) |
| Dec 2023 | $1.59B(+19.5%) | $445.00M(+13.5%) | $1.63B(+6.6%) |
| Sep 2023 | - | $392.00M(-9.0%) | $1.53B(+3.6%) |
| Jun 2023 | - | $431.00M(+18.1%) | $1.48B(+8.8%) |
| Mar 2023 | - | $365.00M(+6.1%) | $1.36B(+2.2%) |
| Dec 2022 | $1.33B(+4.2%) | $344.00M(+1.5%) | $1.33B(+2.5%) |
| Sep 2022 | - | $339.00M(+9.0%) | $1.30B(+0.3%) |
| Jun 2022 | - | $311.00M(-7.4%) | $1.29B(-1.1%) |
| Mar 2022 | - | $336.00M(+7.7%) | $1.31B(+2.6%) |
| Dec 2021 | $1.28B(+0.3%) | $312.00M(-6.9%) | $1.28B(+2.0%) |
| Sep 2021 | - | $335.00M(+2.8%) | $1.25B(+0.9%) |
| Jun 2021 | - | $326.00M(+7.6%) | $1.24B(-0.2%) |
| Mar 2021 | - | $303.00M(+5.6%) | $1.24B(-2.3%) |
| Dec 2020 | $1.27B(-9.3%) | $287.00M(-11.4%) | $1.27B(-2.6%) |
| Sep 2020 | - | $324.00M(-1.5%) | $1.31B(-2.2%) |
| Jun 2020 | - | $329.00M(-0.9%) | $1.33B(-2.3%) |
| Mar 2020 | - | $332.00M(+3.4%) | $1.37B(-2.5%) |
| Dec 2019 | $1.40B(+2.6%) | $321.00M(-9.1%) | $1.40B(+2.7%) |
| Sep 2019 | - | $353.00M(-2.2%) | $1.36B(-0.8%) |
| Jun 2019 | - | $361.00M(-1.6%) | $1.38B(-1.0%) |
| Mar 2019 | - | $367.00M(+29.2%) | $1.39B(+1.8%) |
| Dec 2018 | $1.37B(+0.4%) | $284.00M(-22.0%) | $1.37B(+9.9%) |
| Sep 2018 | - | $364.00M(-2.9%) | $1.24B(-4.2%) |
| Jun 2018 | - | $375.00M(+9.3%) | $1.30B(-5.3%) |
| Mar 2018 | - | $343.00M(+113.0%) | $1.37B(+0.2%) |
| Dec 2017 | $1.36B(-0.5%) | $161.00M(-61.5%) | $1.37B(-11.9%) |
| Sep 2017 | - | $418.00M(-6.7%) | $1.55B(+4.2%) |
| Jun 2017 | - | $448.00M(+31.8%) | $1.49B(+7.7%) |
| Mar 2017 | - | $340.00M(-1.4%) | $1.38B(+1.1%) |
| Dec 2016 | $1.37B(+31.6%) | $345.00M(-2.8%) | $1.37B(+7.0%) |
| Sep 2016 | - | $355.00M(+3.8%) | $1.28B(+9.3%) |
| Jun 2016 | - | $342.00M(+5.2%) | $1.17B(+6.0%) |
| Mar 2016 | - | $325.00M(+27.0%) | $1.10B(+6.2%) |
| Dec 2015 | $1.04B(+7.9%) | $256.00M(+4.1%) | $1.04B(-0.4%) |
| Sep 2015 | - | $246.00M(-10.9%) | $1.04B(+1.0%) |
| Jun 2015 | - | $276.00M(+5.7%) | $1.03B(+2.3%) |
| Mar 2015 | - | $261.00M(+0.4%) | $1.01B(+5.0%) |
| Dec 2014 | $963.00M(+95.7%) | $260.00M(+10.2%) | $962.00M(+15.1%) |
| Sep 2014 | - | $236.00M(-6.7%) | $836.00M(+14.8%) |
| Jun 2014 | - | $253.00M(+18.8%) | $728.00M(+22.1%) |
| Mar 2014 | - | $213.00M(+59.0%) | $596.00M(+19.7%) |
| Dec 2013 | $492.00M | $134.00M(+4.7%) | $498.00M(+3.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | $128.00M(+5.8%) | $482.00M(-1.4%) |
| Jun 2013 | - | $121.00M(+5.2%) | $489.00M(-2.6%) |
| Mar 2013 | - | $115.00M(-2.5%) | $502.00M(-3.3%) |
| Dec 2012 | $519.00M(-6.3%) | $118.00M(-12.6%) | $519.00M(+140.3%) |
| Sep 2012 | - | $135.00M(+0.7%) | $216.00M(-33.9%) |
| Jun 2012 | - | $134.00M(+1.5%) | $327.00M(-25.0%) |
| Mar 2012 | - | $132.00M(-171.4%) | $436.00M(-21.3%) |
| Dec 2011 | $554.00M(-45.8%) | -$185.00M(-175.2%) | $554.00M(-44.4%) |
| Sep 2011 | - | $246.00M(+1.2%) | $996.00M(-2.4%) |
| Jun 2011 | - | $243.00M(-2.8%) | $1.02B(0.0%) |
| Mar 2011 | - | $250.00M(-2.7%) | $1.02B(-0.7%) |
| Dec 2010 | $1.02B(-2.9%) | $257.00M(-5.2%) | $1.03B(+12.1%) |
| Sep 2010 | - | $271.00M(+11.5%) | $917.00M(-2.8%) |
| Jun 2010 | - | $243.00M(-5.4%) | $943.00M(-9.1%) |
| Mar 2010 | - | $257.00M(+76.0%) | $1.04B(-1.5%) |
| Dec 2009 | $1.05B(-20.0%) | $146.00M(-50.8%) | $1.05B(-12.3%) |
| Sep 2009 | - | $297.00M(-11.9%) | $1.20B(-1.4%) |
| Jun 2009 | - | $337.00M(+23.4%) | $1.22B(-0.1%) |
| Mar 2009 | - | $273.00M(-6.8%) | $1.22B(-7.5%) |
| Dec 2008 | $1.32B(+902.0%) | $293.00M(-6.7%) | $1.32B(+28.6%) |
| Sep 2008 | - | $314.00M(-7.1%) | $1.02B(-3.5%) |
| Jun 2008 | - | $338.00M(-9.1%) | $1.06B(+12.4%) |
| Mar 2008 | - | $372.00M(+6.0%) | $944.00M(+30.7%) |
| Sep 2007 | - | $351.00M(+58.8%) | $722.00M(+41.3%) |
| Jun 2007 | - | $221.00M(+47.3%) | $511.00M(+76.2%) |
| Mar 2007 | - | $150.00M(+7.1%) | $290.00M(+107.1%) |
| Sep 2006 | - | $140.00M(-62.4%) | $140.00M(-62.4%) |
| Sep 2005 | - | $372.00M(-532.6%) | $372.00M(>+9900.0%) |
| Jun 2005 | - | -$86.00M(-200.0%) | $0.00(-100.0%) |
| Mar 2005 | - | $86.00M(>+9900.0%) | $86.00M(>+9900.0%) |
| Mar 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2001 | - | $0.00(-100.0%) | $131.44M(0.0%) |
| Dec 2000 | $131.44M(+30.3%) | $131.44M(>+9900.0%) | $131.44M(>+9900.0%) |
| Sep 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2000 | - | $0.00 | $0.00 |
| Dec 1997 | $100.84M(-8.0%) | - | - |
| Dec 1996 | $109.60M(+14.4%) | - | - |
| Dec 1995 | $95.80M(-18.3%) | - | - |
| Dec 1994 | $117.26M(-42.1%) | - | - |
| Dec 1993 | $202.65M(-28.5%) | - | - |
| Dec 1992 | $283.62M(-27.8%) | - | - |
| Dec 1991 | $392.95M(+0.8%) | - | - |
| Dec 1990 | $389.65M | - | - |
FAQ
- What is AstraZeneca annual interest expense?
- What is the all time high annual interest expense for AstraZeneca?
- What is AstraZeneca annual interest expense year-on-year change?
- What is AstraZeneca quarterly interest expense?
- What is the all time high quarterly interest expense for AstraZeneca?
- What is AstraZeneca quarterly interest expense year-on-year change?
- What is AstraZeneca TTM interest expense?
- What is the all time high TTM interest expense for AstraZeneca?
- What is AstraZeneca TTM interest expense year-on-year change?
What is AstraZeneca annual interest expense?
The current annual interest expense of AZN is $1.68B
What is the all time high annual interest expense for AstraZeneca?
AstraZeneca all-time high annual interest expense is $1.68B
What is AstraZeneca annual interest expense year-on-year change?
Over the past year, AZN annual interest expense has changed by +$93.00M (+5.85%)
What is AstraZeneca quarterly interest expense?
The current quarterly interest expense of AZN is $349.00M
What is the all time high quarterly interest expense for AstraZeneca?
AstraZeneca all-time high quarterly interest expense is $457.00M
What is AstraZeneca quarterly interest expense year-on-year change?
Over the past year, AZN quarterly interest expense has changed by -$64.00M (-15.50%)
What is AstraZeneca TTM interest expense?
The current TTM interest expense of AZN is $1.68B
What is the all time high TTM interest expense for AstraZeneca?
AstraZeneca all-time high TTM interest expense is $1.76B
What is AstraZeneca TTM interest expense year-on-year change?
Over the past year, AZN TTM interest expense has changed by -$3.00M (-0.18%)